JP2024503379A5 - - Google Patents
Info
- Publication number
- JP2024503379A5 JP2024503379A5 JP2023541613A JP2023541613A JP2024503379A5 JP 2024503379 A5 JP2024503379 A5 JP 2024503379A5 JP 2023541613 A JP2023541613 A JP 2023541613A JP 2023541613 A JP2023541613 A JP 2023541613A JP 2024503379 A5 JP2024503379 A5 JP 2024503379A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- sequence
- pharmaceutical composition
- fucosyl
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163135479P | 2021-01-08 | 2021-01-08 | |
| US63/135,479 | 2021-01-08 | ||
| PCT/US2022/011564 WO2022150557A1 (en) | 2021-01-08 | 2022-01-07 | Combination therapy using an anti-fucosyl-gm1 antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503379A JP2024503379A (ja) | 2024-01-25 |
| JP2024503379A5 true JP2024503379A5 (cg-RX-API-DMAC7.html) | 2025-01-08 |
Family
ID=80119207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541613A Pending JP2024503379A (ja) | 2021-01-08 | 2022-01-07 | 抗フコシルgm1抗体を使用した組み合わせ療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240050564A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4274850A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024503379A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230129467A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116745322A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022205648A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3204392A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304200A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023007780A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022150557A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201912657D0 (en) * | 2019-09-03 | 2019-10-16 | Scancell Ltd | Binding members |
| WO2026107143A1 (en) * | 2024-11-14 | 2026-05-21 | Bristol-Myers Squibb Company | Fixed dose combination of anti-fucosyl-gm1 antibody and anti-pd-1 antibody and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3530736A3 (en) | 2005-05-09 | 2019-11-06 | ONO Pharmaceutical Co., Ltd. | Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| EA017491B1 (ru) | 2005-12-08 | 2012-12-28 | Медарекс, Инк. | Человеческие моноклональные антитела к фукозил-gm1 и способы применения антифукозил-gm1 антител |
| PT2170959E (pt) | 2007-06-18 | 2014-01-07 | Merck Sharp & Dohme | Anticorpos para o receptor humano de morte programada pd-1 |
| MX356367B (es) | 2008-12-09 | 2018-05-25 | Genentech Inc | Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t. |
| CA2833636A1 (en) | 2011-04-20 | 2012-10-26 | Amplimmune, Inc. | Antibodies and other molecules that bind b7-h1 and pd-1 |
| US9856320B2 (en) | 2012-05-15 | 2018-01-02 | Bristol-Myers Squibb Company | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
| US11104739B2 (en) * | 2016-04-14 | 2021-08-31 | Bristol-Myers Squibb Company | Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody |
| WO2017210631A1 (en) * | 2016-06-03 | 2017-12-07 | Bristol-Myers Squibb Company | Anti-pd-1 antibody for use in a method of treatment of recurrent small cell lung cancer |
| SG11201909064RA (en) * | 2017-03-30 | 2019-10-30 | Merck Patent Gmbh | Combination of an anti-pd-l1 antibody and a dna-pk inhibitor for the treatment of cancer |
| TWI890148B (zh) * | 2018-06-23 | 2025-07-11 | 美商建南德克公司 | 以pd-1軸結合拮抗劑、鉑劑及拓撲異構酶ii抑制劑治療肺癌之方法 |
-
2022
- 2022-01-07 US US18/271,579 patent/US20240050564A1/en active Pending
- 2022-01-07 EP EP22702075.7A patent/EP4274850A1/en active Pending
- 2022-01-07 MX MX2023007780A patent/MX2023007780A/es unknown
- 2022-01-07 JP JP2023541613A patent/JP2024503379A/ja active Pending
- 2022-01-07 CN CN202280009378.0A patent/CN116745322A/zh active Pending
- 2022-01-07 WO PCT/US2022/011564 patent/WO2022150557A1/en not_active Ceased
- 2022-01-07 KR KR1020237026366A patent/KR20230129467A/ko active Pending
- 2022-01-07 AU AU2022205648A patent/AU2022205648A1/en active Pending
- 2022-01-07 CA CA3204392A patent/CA3204392A1/en active Pending
-
2023
- 2023-07-03 IL IL304200A patent/IL304200A/en unknown